Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effect of Different Pelvic Floor Loading Techniques on Women With Stress Urinary Incontinence

19 de junho de 2026 atualizado por: Heba Allah Abd-El-Salam Al-Bahrawy, Cairo University
The purpose of this study is to compare the effects of different pelvic floor loading techniques (graduated positions versus graduated weights) on women with stress urinary incontinence.

Visão geral do estudo

Descrição detalhada

Stress incontinence results from an inability of the urethra to provide adequate resistance to the flow of urine with increased abdominal pressures. From a pathophysiologic perspective, stress incontinence may result from a lack of mechanical urethral support, resulting in urethral hypermobility and/or poor coaptation of the urethral tissues. Normally, forces that occur during the Valsalva maneuver are transmitted to the proximal urethra, resulting in compression of the urethra against the anterior vaginal wall; this process is disrupted in the setting of stress incontinence with urethral hypermobility.

The pelvic floor muscles (PFMs), including the levator ani muscle (LAMs), coccygeus, perineal muscles, striated urethral sphincter (SUS), and external anal sphincter, form the base of the abdomino-pelvic cavity and contribute to the support of the pelvic contents and continence control. The LAMs are considered a functional unit that provides support to the pelvic organs in the transverse plane (lifting) and compresses the urethra against the anterior vagina in the mid-sagittal plane (squeezing). Damage to or dysfunction of the LAMs is thought to be a contributor to stress urinary incontinence (SUI).

PFM-training, the most commonly used physical therapy treatment for women with SUI, is effective and therefore recommended as a first-line therapy.

According to traditional recommendations for PFM training programs, it is important to consider a gradual progression in the difficulty of the exercises, starting with less demanding positions (supine, standing, or side plank) and progressing to more complex challenges (quadruped hold, plank, and squat).

Vaginal Weights may be an effective training aid for women with mild to moderate stress incontinence, particularly in the absence of severe pelvic organ prolapse. They also may be useful for pelvic floor strengthening during the immediate postpartum period, as a behavioral program for continence maintenance, and for self-management programs.

Tipo de estudo

Intervencional

Inscrição (Estimado)

40

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

      • Cairo, Egito
        • Heba Allah Abdel salam Al-Bahrawy

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • All women are suffering from Stress urinary incontinence.
  • Their age will range from 30-40 years.
  • Their body mass index will range from 25-30 kg/m2.
  • They are multiparous women (2-3 times).

Exclusion Criteria:

  • Patient with denervated pelvic floor muscle, urinary tract infection, severe prolapse of pelvic organs, fibroid uterus, or intrauterine devices.
  • Renal disease, pulmonary illness, chronic cough, and constipation.
  • Underwent surgery for stress urinary incontinence.
  • Other types of urinary incontinence (e.g., urge incontinence and mixed incontinence).
  • Diabetic patients.
  • Patient with anatomic changes (ectopic ureter, genito-urinary fistula)
  • Patient with knee or back symptoms (Osteoarthritis or lumbar disc).

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Pelvic floor exercises with graduated loading positions group
The participants will perform pelvic floor exercises with graduated loading positions, 3 sessions per week, for 12 weeks.

The participants will be instructed to perform and repeat each exercise 10 times to build core muscle strength. They will then maintain the position comfortably for 1-5 minutes without engaging the pelvic floor muscles. Afterward, they will begin pelvic floor muscle exercises from each position, including quick flicks, slow contractions, and sustained contractions. The maintenance time will be gradually increased.

Each position will be performed under both stable and unstable conditions:

(i) Stable side-lying position, with lateral support of the body on the floor (ii) Unstable side-lying position, side plank. (iii) Stable quadruped, with support of the knees on the floor. (iv) Unstable quadruped, off-knees quadruped hold. (v) Stable standing, with support of the back against the wall. (vi) Unstable standing, without support. (vii) Stable squat, or wall squat with back supported against the wall. (viii) Unstable squat, parallel squat

Experimental: Pelvic floor exercises with graduated vaginal weights group
The participants will perform pelvic floor exercises with graduated vaginal weights, 3 sessions per week, for 12 weeks.

The participants will perform pelvic floor exercises using graduated vaginal weights (cones). The vaginal cone is inserted into the vagina, and pelvic muscle contractions are used to hold it in place during a standing position. The procedure will begin with the lightest cone (white), in a position preferred by each patient. After inserting the vaginal cone, the pelvic muscles will contract for around 2 seconds to hold the cone in place.

Initially, contractions of a few seconds will be repeated 10 times, with rest periods of 5-10 seconds between each contraction. As the patient progresses, the contraction duration will gradually increase. To determine when to move to the next cone with a heavier weight, the following exercises will be performed: walking for at least one minute, going up and down the stairs, jumping on the spot for at least thirty seconds, coughing 10 to 15 times, and washing hands under cold water for one minute.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Assessment of pelvic floor muscle strength
Prazo: 3 months
The Kegel perineometer will be used to assess pelvic floor muscle strength. It provides an indirect measure of strength generated via a change in pressure within a balloon connected to a pressure sensor. A vaginal probe designed to detect pressure changes is inserted within the vaginal canal, as first developed by Kegel. This pressure change reflects muscular force, as the largest change from resting pressure to peak pressure recorded during the contraction. it can also measure the endurance by recording repeated and sustained contractions, which reflect the overall muscular capability of both slow and fast-twitch fiber activity. The Perineometer is considered a highly reproducible and reliable tool, showing the pressure (in millimeters of mercury) as a measure of PFM strength. Vaginal squeeze pressure that is normally around 40 to 60 mmHg.
3 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Measurement of urethral angle (α)
Prazo: 3 months
Ultrasonography is a reliable, non-invasive, and comfortable method that provides dynamic evaluation in the examination of urethral mobility. Transperineal ultrasonography has also been introduced to evaluate the mobility of the bladder neck and proximal urethra by measuring the urethral angle, the angle between the proximal urethra axis and the long axis of the symphysis pubis (α angle) during rest comfortably filled bladder. Patients will be asked to fully strain by verbally directing to push and cough, and the maximum Valsalva image will be obtained with the help of cine-loop function, and the new angle will be measured. The differences of angles at rest and strain (rotation angles) will be recorded as the urethral angle (α).
3 months
Assessment of stress urinary incontinence Severity
Prazo: 3 months
Urinary Incontinence Severity Index will be used to assess stress urinary incontinence severity. It is a valid questionnaire consisting of two questions that determine an overall score by multiplying the frequency of urinary incontinence and the quantity of urine leakage. The severity will be categorized as mild (1-2), moderate (3-6), severe (8-9), and extremely severe (12).
3 months
Assessment of stress urinary incontinence Impact on Quality of Life
Prazo: 3 months
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) will be used to assess quality of life(QoL). This is a simple and brief self-administered questionnaire consisting of six questions. The first two questions address demographic variables, while the next four questions focus on the frequency, amount of leakage, and overall impact on QOL. Additionally, a non-scored item assesses the type of incontinence. Scoring will range from 0 to 21, with higher scores indicating increased severity
3 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Cadeira de estudo: khadyga Abdul Aziz, Professor, Cairo University
  • Diretor de estudo: Hossam Kamel, professor, Al-Azhar University

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de junho de 2026

Conclusão Primária (Estimado)

15 de dezembro de 2026

Conclusão do estudo (Estimado)

30 de dezembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

16 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de junho de 2026

Primeira postagem (Real)

22 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

24 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

19 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever